Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer. (Q44879834)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122077%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122077%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

main subject

phase I clinical trial

0 references

patient

0 references

author

Harikrishna Nakshatri

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122077%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Eardie A Curry

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122077%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Daryl J Murry

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122077%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Christy Yoder

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122077%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Karen Fife

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122077%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Victoria Armstrong

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122077%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Michael O'Connell

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122077%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Christopher J Sweeney

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122077%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 August 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122077%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122077%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122077%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122077%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

299-305

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122077%20AND%20SRC:MED&resulttype=core&format=json

A platelet phospholipase inhibitor from the medicinal herb feverfew (Tanacetum parthenium)

28 December 2019

cites work

1 reference

12 December 2020

Herbal composition PC-SPES for management of prostate cancer: identification of active principles.

1 reference

12 December 2020

Multidrug resistance--a multiplex phenomenon

1 reference

12 December 2020

Feverfew in rheumatoid arthritis: a double blind, placebo controlled study

1 reference

12 December 2020

Efficacy of feverfew as prophylactic treatment of migraine

1 reference

12 December 2020

Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion

1 reference

12 December 2020

Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes

1 reference

12 December 2020

Feverfew as a preventive treatment for migraine: a systematic review

1 reference

12 December 2020

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

1 reference

12 December 2020

Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials

1 reference

12 December 2020

PC-SPES: A cautionary tale

1 reference

12 December 2020

Prostaglandin synthetase inhibitors in feverfew

1 reference

12 December 2020

Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide

1 reference

12 December 2020

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

1 reference

12 December 2020

Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta

1 reference

12 December 2020

Inhibition of 5-lipoxygenase and cyclo-oxygenase in leukocytes by feverfew. Involvement of sesquiterpene lactones and other components

1 reference

12 December 2020

Randomised double-blind placebo-controlled trial of feverfew in migraine prevention

1 reference

12 December 2020

Complementary medicines industry in crisis after recall of 1546 products

1 reference

12 December 2020

Promotion of microtubule assembly in vitro by taxol

1 reference

12 December 2020

Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF-kappaB.

1 reference

12 December 2020

Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia

1 reference

12 December 2020

Patient numbers needed in prophylactic migraine trials.

1 reference

12 December 2020